Patent ID: 8883863
Filing Date: 2014-11-11
Classification: A61K,C07B,C07C,C07D

Abstract:
1. A pharmaceutical drug product comprising at least one drug substance selected from the group consisting of: amorphous sibutramine pamoate characterized by at least one method selected from: polymorphic sibutramine pamoate characterized by at least one method selected from: amorphous nortriptyline pamoate characterized by at least one method selected from: polymorphic nortriptyline pamoate characterized by at least one method selected from: amorphous clomipramine pamoate characterized by at least one method selected from: polymorphic clomipramine pamoate characterized by at least one method selected from: amorphous promethazine pamoate characterized by at least one method selected from: and polymorphic promethazine pamoate characterized by at least one method selected from: